BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14575766)

  • 1. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
    Sasaki Md; Foccacia R; de Messias-Reason IJ
    Vaccine; 2003 Nov; 21(31):4545-9. PubMed ID: 14575766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine.
    Tarr PE; Lin R; Mueller EA; Kovarik JM; Guillaume M; Jones TC
    Vaccine; 1996 Sep; 14(13):1199-204. PubMed ID: 8961505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
    Overton ET; Kang M; Peters MG; Umbleja T; Alston-Smith BL; Bastow B; Demarco-Shaw D; Koziel MJ; Mong-Kryspin L; Sprenger HL; Yu JY; Aberg JA
    Vaccine; 2010 Aug; 28(34):5597-604. PubMed ID: 20600512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant.
    Looney RJ; Hasan MS; Coffin D; Campbell D; Falsey AR; Kolassa J; Agosti JM; Abraham GN; Evans TG
    J Clin Immunol; 2001 Jan; 21(1):30-6. PubMed ID: 11321236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
    Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
    J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
    Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
    J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis.
    Cruciani M; Mengoli C; Serpelloni G; Mazzi R; Bosco O; Malena M
    Vaccine; 2007 Jan; 25(4):709-18. PubMed ID: 16963165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
    Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
    Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults.
    Hasan MS; Agosti JM; Reynolds KK; Tanzman E; Treanor JJ; Evans TG
    J Infect Dis; 1999 Dec; 180(6):2023-6. PubMed ID: 10558962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study on the combined therapy of granulocyte-macrophage colony-stimulating factor and hepatitis B vaccine on chronic hepatitis B virus carrier children.
    Wang J; Zhu Q; Zhang T; Yu H
    Chin Med J (Engl); 2002 Dec; 115(12):1824-8. PubMed ID: 12622932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
    Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C
    APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Fabrizi F; Ganeshan SV; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response.
    Kim MJ; Nafziger AN; Harro CD; Keyserling HL; Ramsey KM; Drusano GL; Bertino JS
    Vaccine; 2003 Mar; 21(11-12):1174-9. PubMed ID: 12559795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients.
    Anandh U; Bastani B; Ballal S
    Am J Nephrol; 2000; 20(1):53-6. PubMed ID: 10644869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Surface Antigen Seroconversion by Interferon-
    Li S; Luo S; Lei Q; Meng Z
    Viral Immunol; 2020 Mar; 33(2):122-125. PubMed ID: 31880508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte macrophage colony stimulating factor augmented hepatitis B vaccine protocol for rapid seroprotection in voluntary kidney donors.
    Krishnamurthy K; John GT; Abraham P; Jacob CK
    Indian J Med Res; 2004 Apr; 119(4):162-4. PubMed ID: 15147122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
    Singh NP; Mandal SK; Thakur A; Kapoor D; Anuradha S; Prakash A; Kohli R; Agarwal SK
    Ren Fail; 2003 Mar; 25(2):255-66. PubMed ID: 12739832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.